Aspira Women’s Health (AWH) announced the appointment of Ellen Beausang to the Board of Directors, effective February 10, 2025. Beausang has been in an executive role at BioReference Health holding the role of Chief Commercial Officer since 2022.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AWH:
- Aspira Women’s Health Announces Leadership Changes in 2025
- Aspira Women’s Health Announces Key Leadership Changes
- Aspira Women’s Health appoints Mike Buhle as SVP, commercial operations
- Aspira Women’s Health interim CFO John Kallassy to depart
- Aspira Women’s Health files to sell 16M shares of common stock, warrants